Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry C Wienkers

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Combinatorial Chemistry & High Throughput Screening|March 27, 2010
Preclinical profiling in drug discovery. EditorialLarry C Wienkers
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 30, 2002
Factors confounding the successful extrapolation of in vitro CYP3A inhibition information to the in vivo conditionLarry C Wienkers
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Multienzyme kinetics and sequential metabolismLarry C Wienkers, Brooke Rock
Nature Reviews. Drug Discovery|October 15, 2005
Predicting in vivo drug interactions from in vitro drug discovery dataLarry C Wienkers, Timothy G Heath
Methods in Molecular Biology (Clifton, N.J.)|July 17, 2021
Multienzyme Kinetics and Sequential MetabolismLarry C Wienkers, Brooke M Rock
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Multiple cytochrome P450 enzymes responsible for the oxidative metabolism of the substituted (S)-3-phenylpiperidine, (S,S)-3-[3-(methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride, in human liver microsomesLarry C Wienkers, Michael A Wynalda
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 17, 2024
Beyond cytotoxic potency: disposition features required to design ADC payloadHao Sun, Larry C Wienkers, Anthony Lee
Current Opinion in Drug Discovery & Development|February 1, 2005
Predicting drug-drug interactions in drug discovery: where are we now and where are we going?Matthew Hutzler, Dean M Messing, Larry C Wienkers
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 10, 2006
The in vitro drug interaction potential of dietary supplements containing multiple herbal componentsRobert S Foti, Jan L Wahlstrom, Larry C Wienkers
Chemical Research in Toxicology|April 22, 2003
Inhibition of cytochrome P450 2D6: structure-activity studies using a series of quinidine and quinine analoguesJ Matthew Hutzler, Gregory S Walker, Larry C Wienkers
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Combinatorial Chemistry & High Throughput Screening|March 27, 2010
Preclinical profiling in drug discovery. EditorialLarry C Wienkers
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 30, 2002
Factors confounding the successful extrapolation of in vitro CYP3A inhibition information to the in vivo conditionLarry C Wienkers
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Multienzyme kinetics and sequential metabolismLarry C Wienkers, Brooke Rock
Nature Reviews. Drug Discovery|October 15, 2005
Predicting in vivo drug interactions from in vitro drug discovery dataLarry C Wienkers, Timothy G Heath
Methods in Molecular Biology (Clifton, N.J.)|July 17, 2021
Multienzyme Kinetics and Sequential MetabolismLarry C Wienkers, Brooke M Rock
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Multiple cytochrome P450 enzymes responsible for the oxidative metabolism of the substituted (S)-3-phenylpiperidine, (S,S)-3-[3-(methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride, in human liver microsomesLarry C Wienkers, Michael A Wynalda
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 17, 2024
Beyond cytotoxic potency: disposition features required to design ADC payloadHao Sun, Larry C Wienkers, Anthony Lee
Current Opinion in Drug Discovery & Development|February 1, 2005
Predicting drug-drug interactions in drug discovery: where are we now and where are we going?Matthew Hutzler, Dean M Messing, Larry C Wienkers
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 10, 2006
The in vitro drug interaction potential of dietary supplements containing multiple herbal componentsRobert S Foti, Jan L Wahlstrom, Larry C Wienkers
Chemical Research in Toxicology|April 22, 2003
Inhibition of cytochrome P450 2D6: structure-activity studies using a series of quinidine and quinine analoguesJ Matthew Hutzler, Gregory S Walker, Larry C Wienkers
Pageof 5